Jump Financial’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Jump Financial’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,418	Closed	-$84.2K	–	2190
2022 Q4	$84.2K	Sell	14,418 -21,782	-60%	-$115K	﹤0.01%	1448
2022 Q3	$243K	Buy	+36,200	New	+$219K	0.01%	1260
2021 Q3	–	Sell	-36,533	Closed	-$154K	–	1632
2021 Q2	$154K	Buy	+36,533	New	+$155K	0.01%	925

Jump Financial's CNCE Position: Q1 2023 in Review

Jump Financial sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 14,418 shares — an estimated $84.2K sold.

Jump Financial first reported a position in CNCE in Q2 2021 and held it in 3 quarters. The position peaked at $243K in Q3 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

Jump Financial reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Jump Financial sold 14,418 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $84.2K.
Jump Financial first reported a position in Concert Pharmaceuticals, Inc. in Q2 2021 and held it in 3 quarters.
Jump Financial's Concert Pharmaceuticals, Inc. position peaked at $243K in Q3 2022.
0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Jump Financial's 13F filing for Q1 2023, filed 3 May 2023.